Delivery Order SPE2DB22D2006-SPE2DB24FW2AP

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.08 Firm Fixed Price Delivery Order covers the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a period of performance through December 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,108.55, is a Firm Fixed Price Delivery Order to provide Estrogen-Methyltestos H.S. Tablets in 100 count sizes. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,711.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a pharmaceutical product, with a completion date of September 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,230.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of "ESTROGEN-METHYLTESTOS F.S. TAB 100S," a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
This federal contract award, solicited by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,310.45 delivery order covers the supply of Estrogen-Methyltestos H.S. Tablets in quantities of 100s to support military and government healthcare programs. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a delivery order valued at $3,046.82 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos H.S. Tab 100s, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $1,346.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos F.S. Tablets in quantities of 100s, with a completion date of June 22, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,643.61 Firm Fixed Price Delivery Order contract is for the provision of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a pharmaceutical product. The contract has a completion date of February 12, 2025 and was awarded on February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $1,888.16 and covers the supply of Estrogen-Methyltestos H.S. Tablets in 100-count packages. The contract has an ultimate completion date of December 8, 2023 and is a firm fixed-price contract. The contract was awarded on December 7, 2023 and does not have a set-aside designation, indicating it was...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2AP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,244.70 firm fixed-price delivery order is for the supply of Estrogen-Methyltestos F.S. Tablets in 100-count packages. This award is not associated with a set-aside program and has a completion date of July 19, 2024. Amerisourcebergen, as a prime contractor, has previously been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000, respectively, for delivering a broad range of essential pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare programs.

Generated 10/17/24, 9:37 AM